Later they utilized CD208 (DC-LAMP)marker for marking MDCs and proved that CD208+ DCs were detectable in the peritumoral area, and infiltration of MDCs into tumor epithelium was correlated also with decreased patient survival[4]. The gene discussed is LAMP3; the disease is neoplasm.